The study tests the efficacy of a non-invasive device with low intensity electromagnetic field dedicated treatment to enhance the recovery of stroke patients impaired hand motor function
The study investigates the effect of BCI based stimulation device on upper limb motor function of acute stroke patients. The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
28
The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.
Sham BQ device
BLK super specialty hospital
New Delhi, India
Fugl Meyer Assessment of Upper Extremity (FMA-UE)
FMA score of upper limb, range between 0 to 66 (higher the better)
Time frame: Two months
ARAT
Action Research Arm test
Time frame: two months
BBT
Box and Blocks test
Time frame: two months
TMT
Trail making test
Time frame: two months
NIHSS
The national institutes of health stroke scale, a 0 to 42 scale, the higher the worse.
Time frame: two months
Promis 10
The PROMIS Global Health short form, 10 questions questionnaire, calculated through a look up t-score table
Time frame: two months
MoCA
Montreal cognitive assessment
Time frame: two months
mRs
modified Rankin scale, a 0 to 6 scale, the higher the worse
Time frame: two months
MRI-DTI
magnetic resonance imaging, diffusion tensor imaging
Time frame: two months
brain recovery biomarkers
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
UCH-L1, and GFAP
Time frame: two months